{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:33:18Z","timestamp":1787506398452,"version":"build-2736575974"},"reference-count":313,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["98029520"],"award-info":[{"award-number":["98029520"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015035","name":"National Foundation of Elites","doi-asserted-by":"publisher","award":["4026720"],"award-info":[{"award-number":["4026720"]}],"id":[{"id":"10.13039\/501100015035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R276-2018-671"],"award-info":[{"award-number":["R276-2018-671"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R453-2024-359"],"award-info":[{"award-number":["R453-2024-359"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbadis.2025.167862","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T18:55:58Z","timestamp":1745002558000},"page":"167862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Parkinson's disease and gut microbiota metabolites: The dual impact of vitamins and functional amyloids"],"prefix":"10.1016","volume":"1871","author":[{"given":"Fatemeh","family":"Mirab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Pirhaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Otzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Saboury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167862_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2015.12.085","article-title":"The status of glycation in protein aggregation","author":"Taghavi","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016075","article-title":"Large proteins have a great tendency to aggregate but a low propensity to form amyloid fibrils","volume":"6","author":"Ramshini","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.167862_bb0020","doi-asserted-by":"crossref","unstructured":"Uversky, V.; Eliezer, D. Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein. Curr. Protein Pept. Sci. 2009, 10 (5), 483\u2013499. doi:https:\/\/doi.org\/10.2174\/138920309789351921.","DOI":"10.2174\/138920309789351921"},{"key":"10.1016\/j.bbadis.2025.167862_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-022-01150-0","article-title":"Alpha-Synuclein: a pathological factor with a\u03b2 and tau and biomarker in Alzheimer\u2019s disease","author":"Shim","year":"2022","journal-title":"Alzheimer\u2019s Research and Therapy."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-10789-6","article-title":"Mechanisms of enhanced aggregation and fibril formation of Parkinson\u2019s disease-related variants of \u03b1-Synuclein","volume":"12","author":"Ohgita","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167862_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.167992","article-title":"Common mechanisms underlying \u03b1-Synuclein-induced mitochondrial dysfunction in Parkinson\u2019s disease","author":"Sohrabi","year":"2023","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-32075-9","article-title":"Modulation of cytotoxic amyloid fibrillation and mitochondrial damage of \u03b1-Synuclein by Catechols mediated conformational changes","volume":"13","author":"Zohoorian-Abootorabi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167862_bb0045","doi-asserted-by":"crossref","unstructured":"Dehghani, Z.; Meratan, A. A.; Saboury, A. A.; Nemat-Gorgani, M. \u0391-Synuclein fibrillation products trigger the release of hexokinase I from mitochondria: protection by curcumin, and possible role in pathogenesis of Parkinson's disease. Biochim. Biophys. Acta Biomembr. 2020, 1862 (6). doi:https:\/\/doi.org\/10.1016\/j.bbamem.2020.183251.","DOI":"10.1016\/j.bbamem.2020.183251"},{"key":"10.1016\/j.bbadis.2025.167862_bb0050","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.3c01167","article-title":"Cell-penetrating peptides: promising therapeutics and drug-delivery Systems for Neurodegenerative Diseases","author":"Pirhaghi","year":"2024","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167862_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083752","article-title":"Structural and dynamical insights into the membrane-bound \u03b1-Synuclein","volume":"8","author":"Jain","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2025.167862_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.94","article-title":"Alpha-Synuclein: from secretion to dysfunction and death","author":"Marques","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb0065","first-page":"23 (2)","article-title":"Structural insights on physiological functions and pathological effects of \u00b1-synuclein","author":"Bisaglia","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2025.167862_bb0070","doi-asserted-by":"crossref","unstructured":"Gallegos, S.; Pacheco, C.; Peters, C.; Opazo, C.; Aguayo, L. G. Features of Alpha-Synuclein That Could Explain the Progression and Irreversibility of Parkinson's Disease. Front Neurosci 2015, 9 (FEB). doi:https:\/\/doi.org\/10.3389\/fnins.2015.00059.","DOI":"10.3389\/fnins.2015.00059"},{"key":"10.1016\/j.bbadis.2025.167862_bb0075","doi-asserted-by":"crossref","unstructured":"Rodriguez, J. A.; Ivanova, M. I.; Sawaya, M. R.; Cascio, D.; Reyes, F. E.; Shi, D.; Sangwan, S.; Guenther, E. L.; Johnson, L. M.; Zhang, M.; Jiang, L.; Arbing, M. A.; Nannenga, B. L.; Hattne, J.; Whitelegge, J.; Brewster, A. S.; Messerschmidt, M.; Boutet, S.; Sauter, N. K.; Gonen, T.; Eisenberg, D. S. Structure of the toxic Core of \u03b1-Synuclein from invisible crystals. Nature 2015, 525 (7570). doi:https:\/\/doi.org\/10.1038\/nature15368.","DOI":"10.1038\/nature15368"},{"key":"10.1016\/j.bbadis.2025.167862_bb0080","article-title":"Alpha-Synuclein structure, functions, and interactions","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/S0047-6374(01)00283-4","article-title":"Alpha Synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson\u2019s disease?","author":"Rajagopalan","year":"2001","journal-title":"Mech. Ageing Dev."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15472-4","article-title":"Bivalent metal ions induce formation of \u03b1-Synuclein fibril polymorphs with different Cytotoxicities","volume":"12","author":"Atarod","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167862_bb0095","doi-asserted-by":"crossref","unstructured":"Pirhaghi, M.; Frank, S. A.; Alam, P.; Nielsen, J.; Sereikaite, V.; Gupta, A.; Str\u00f8mgaard, K.; Andreasen, M.; Sharma, D.; Saboury, A. A.; Otzen, D. E. A Penetratin-derived peptide reduces the membrane Permeabilization and cell toxicity of \u03b1-Synuclein oligomers. J. Biol. Chem. 2022, 298 (12). doi:https:\/\/doi.org\/10.1016\/j.jbc.2022.102688.","DOI":"10.1016\/j.jbc.2022.102688"},{"key":"10.1016\/j.bbadis.2025.167862_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"\u0391-Synuclein Misfolding and Parkinson\u2019s disease","author":"Breydo","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u0391-Synuclein Misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis","author":"Mehra","year":"2019","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.bbadis.2025.167862_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.crstbi.2022.11.002","article-title":"Amyloid management by chaperones: the mystery underlying protein oligomers\u2019 dual functions","author":"Arghavani","year":"2022","journal-title":"Current Research in Structural Biology."},{"key":"10.1016\/j.bbadis.2025.167862_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2025.167862_bb0120","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments","author":"Maiti","year":"2017","journal-title":"Translational Neurodegeneration."},{"key":"10.1016\/j.bbadis.2025.167862_bb0130","doi-asserted-by":"crossref","unstructured":"Betarbet, R.; Sherer, T. B.; Greenamyre, J. T. Ubiquitin\u2013Proteasome System and Parkinson's Diseases. Exp. Neurol. 2005, 191, S17\u2013S27. doi:https:\/\/doi.org\/10.1016\/j.expneurol.2004.08.021.","DOI":"10.1016\/j.expneurol.2004.08.021"},{"key":"10.1016\/j.bbadis.2025.167862_bb0135","doi-asserted-by":"crossref","unstructured":"Liang, Y.; Zhong, G.; Ren, M.; Sun, T.; Li, Y.; Ye, M.; Ma, C.; Guo, Y.; Liu, C. The Role of Ubiquitin\u2013Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease. NeuroMolecular Med. 2023. doi:https:\/\/doi.org\/10.1007\/s12017-023-08755-0.","DOI":"10.1007\/s12017-023-08755-0"},{"key":"10.1016\/j.bbadis.2025.167862_bb0140","doi-asserted-by":"crossref","unstructured":"Suganya, K.; Koo, B. S. Gut\u2013Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics\/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. Int. J. Mol. Sci. 2020. doi:https:\/\/doi.org\/10.3390\/ijms21207551.","DOI":"10.3390\/ijms21207551"},{"key":"10.1016\/j.bbadis.2025.167862_bb0145","doi-asserted-by":"crossref","unstructured":"Klann, E. M.; Dissanayake, U.; Gurrala, A.; Farrer, M.; Shukla, A. W.; Ramirez-Zamora, A.; Mai, V.; Vedam-Mai, V. The Gut\u2013Brain Axis and Its Relation to Parkinson's Disease: A Review. Front. Aging Neurosci. 2022. doi:https:\/\/doi.org\/10.3389\/fnagi.2021.782082.","DOI":"10.3389\/fnagi.2021.782082"},{"key":"10.1016\/j.bbadis.2025.167862_bb0150","doi-asserted-by":"crossref","unstructured":"Mayer, E. A. Gut feelings: the emerging biology of gut-\"brain communication. Nat. Rev. Neurosci. 2011. doi:https:\/\/doi.org\/10.1038\/nrn3071.","DOI":"10.1038\/nrn3071"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12640-023-00681-0","article-title":"Gut-brain Axis deregulation and its possible contribution to neurodegenerative disorders","volume":"42","author":"Villavicencio-Tejo","year":"2024","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbadis.2025.167862_bb0160","series-title":"The Gut-Brain Axis: Is Intestinal Inflammation a Silent Driver of Parkinson\u2019s Disease Pathogenesis? Npj Parkinson\u2019s Disease","author":"Houser","year":"2017"},{"key":"10.1016\/j.bbadis.2025.167862_bb0165","doi-asserted-by":"crossref","unstructured":"Braak, H.; R\u00fcb, U.; Gai, W. P.; Del Tredici, K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to Neuroinvasion by an unknown pathogen. J. Neural Transm. 2003, 110 (5). doi:https:\/\/doi.org\/10.1007\/s00702-002-0808-2.","DOI":"10.1007\/s00702-002-0808-2"},{"key":"10.1016\/j.bbadis.2025.167862_bb0170","doi-asserted-by":"crossref","unstructured":"Rietdijk, C. D.; Perez-Pardo, P.; Garssen, J.; van Wezel, R. J. A.; Kraneveld, A. D. Exploring Braak's Hypothesis of Parkinson's Disease. Front Neurol 2017, 8 (FEB). doi:https:\/\/doi.org\/10.3389\/fneur.2017.00037.","DOI":"10.3389\/fneur.2017.00037"},{"key":"10.1016\/j.bbadis.2025.167862_bb0175","article-title":"The staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered","volume":"2006","author":"Braak","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb0180","doi-asserted-by":"crossref","unstructured":"Alfonsetti, M.; Castelli, V.; D'angelo, M. Are We What We Eat? Impact of Diet on the Gut\u2013Brain Axis in Parkinson's Disease. Nutrients. 2022. doi:https:\/\/doi.org\/10.3390\/nu14020380.","DOI":"10.3390\/nu14020380"},{"key":"10.1016\/j.bbadis.2025.167862_bb0185","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-191721","article-title":"Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-023-02633-6","article-title":"The brain-first vs. body-first model of Parkinson\u2019s disease with comparison to alternative models","author":"Borghammer","year":"2023","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2025.167862_bb0195","article-title":"Therapies for Parkinson\u2019s disease and the gut microbiome: evidence for bidirectional connection","author":"Hey","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0200","doi-asserted-by":"crossref","DOI":"10.1007\/s40473-017-0129-2","article-title":"Microbes tickling your tummy: the importance of the gut-brain Axis in Parkinson\u2019s disease","author":"Perez-Pardo","year":"2017","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"10.1016\/j.bbadis.2025.167862_bb0205","article-title":"Microbiome","author":"Miraglia","year":"2019","journal-title":"Parkinson\u2019s Disease and Molecular Mimicry. Cells."},{"key":"10.1016\/j.bbadis.2025.167862_bb0210","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20180448","article-title":"The gut microbiome: relationships with disease and opportunities for therapy","author":"Durack","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2025.167862_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/nn.4476","article-title":"Interactions between the microbiota, immune and nervous Systems in Health and Disease","author":"Fung","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0220","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2019.1638722","article-title":"Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health","author":"Parker","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbadis.2025.167862_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(03)12489-0","article-title":"Gut Flora in health and disease","author":"Guarner","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2025.167862_bb0230","unstructured":"Quigley, E. M. M. Gut Bacteria in Health and Disease. Gastroenterol Hepatol (N Y) 2013, 9 (9)."},{"key":"10.1016\/j.bbadis.2025.167862_bb0235","doi-asserted-by":"crossref","unstructured":"Buret, A. G.; Allain, T. Gut microbiota biofilms: from regulatory mechanisms to therapeutic targets. J. Exp. Med. 2023, 220 (3). doi:https:\/\/doi.org\/10.1084\/jem.20221743.","DOI":"10.1084\/jem.20221743"},{"key":"10.1016\/j.bbadis.2025.167862_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2025.167862_bb0245","first-page":"32","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb0250","doi-asserted-by":"crossref","unstructured":"Scheperjans, F.; Aho, V.; Pereira, P. A. B.; Koskinen, K.; Paulin, L.; Pekkonen, E.; Haapaniemi, E.; Kaakkola, S.; Eerola-Rautio, J.; Pohja, M.; Kinnunen, E.; Murros, K.; Auvinen, P. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. 2015, 30 (3). doi:https:\/\/doi.org\/10.1002\/mds.26069.","DOI":"10.1002\/mds.26069"},{"issue":"11","key":"10.1016\/j.bbadis.2025.167862_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142164","article-title":"Intestinal Dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2025.167862_bb0260","doi-asserted-by":"crossref","unstructured":"Sampson, T. R.; Debelius, J. W.; Thron, T.; Janssen, S.; Shastri, G. G.; Ilhan, Z. E.; Challis, C.; Schretter, C. E.; Rocha, S.; Gradinaru, V.; Chesselet, M. F.; Keshavarzian, A.; Shannon, K. M.; Krajmalnik-Brown, R.; Wittung-Stafshede, P.; Knight, R.; Mazmanian, S. K. Gut microbiota regulate motor deficits and Neuroinflammation in a model of Parkinson's disease. Cell 2016, 167 (6). doi:https:\/\/doi.org\/10.1016\/j.cell.2016.11.018.","DOI":"10.1016\/j.cell.2016.11.018"},{"key":"10.1016\/j.bbadis.2025.167862_bb0265","doi-asserted-by":"crossref","unstructured":"Holmqvist, S.; Chutna, O.; Bousset, L.; Aldrin-Kirk, P.; Li, W.; Bj\u00f6rklund, T.; Wang, Z. Y.; Roybon, L.; Melki, R.; Li, J. Y. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014, 128 (6). doi:https:\/\/doi.org\/10.1007\/s00401-014-1343-6.","DOI":"10.1007\/s00401-014-1343-6"},{"key":"10.1016\/j.bbadis.2025.167862_bb0270","doi-asserted-by":"crossref","unstructured":"Lohmann, S.; Bernis, M. E.; Tachu, B. J.; Ziemski, A.; Grigoletto, J.; Tamg\u00fcney, G. Oral and intravenous transmission of \u03b1-Synuclein fibrils to mice. Acta Neuropathol. 2019, 138 (4). doi:https:\/\/doi.org\/10.1007\/s00401-019-02037-5.","DOI":"10.1007\/s00401-019-02037-5"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0275","article-title":"Autonomic ganglionic injection of \u03b1-Synuclein fibrils as a model of pure autonomic failure \u03b1-Synucleinopathy","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167862_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-Synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2025.167862_bb0285","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-202085","article-title":"Crosstalk between alpha-Synuclein and other human and non-human Amyloidogenic proteins: consequences for amyloid formation in Parkinson\u2019s disease","author":"Werner","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb0290","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Calvet, A.; Matilla-Cuenca, L.; Izco, M.; Navarro, S.; Serrano, M.; Ventura, S.; Blesa, J.; Herr\u00e1iz, M.; Alkorta-Aranburu, G.; Galera, S.; Ruiz de los Mozos, I.; Mansego, M. L.; Toledo-Arana, A.; Alvarez-Erviti, L.; Valle, J. Gut Microbiota Produces Biofilm-Associated Amyloids with Potential for Neurodegeneration. Nat Commun 2024, 15 (1), 4150. doi:https:\/\/doi.org\/10.1038\/s41467-024-48309-x.","DOI":"10.1038\/s41467-024-48309-x"},{"key":"10.1016\/j.bbadis.2025.167862_bb0295","article-title":"Functions of gut microbiota metabolites, current status and future perspectives","author":"Liu","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb0300","doi-asserted-by":"crossref","DOI":"10.1039\/D2SC00645F","article-title":"Functional amyloids from bacterial biofilms - structural properties and interaction partners","author":"Akbey","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2958.2010.07269.x","article-title":"Functional amyloid in Pseudomonas","volume":"77","author":"Dueholm","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: An emergent form of bacterial life","author":"Flemming","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2021.01.001","article-title":"Unravelling the role of gut microbiota in Parkinson\u2019s disease progression: pathogenic and therapeutic implications","author":"Rani","year":"2021","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbadis.2025.167862_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2012.08.005","article-title":"Bacteria as vitamin suppliers to their host: a gut microbiota perspective","author":"LeBlanc","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167862_bb0330","doi-asserted-by":"crossref","unstructured":"Geva-Zatorsky, N.; Sefik, E.; Kua, L.; Pasman, L.; Tan, T. G.; Ortiz-Lopez, A.; Yanortsang, T. B.; Yang, L.; Jupp, R.; Mathis, D.; Benoist, C.; Kasper, D. L. Mining the human gut microbiota for immunomodulatory organisms. Cell 2017, 168 (5). doi:https:\/\/doi.org\/10.1016\/j.cell.2017.01.022.","DOI":"10.1016\/j.cell.2017.01.022"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167862_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-017-0089-z","article-title":"Dynamics of Metatranscription in the inflammatory bowel disease gut microbiome","volume":"3","author":"Schirmer","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2015.11.012","article-title":"Gut microbiome in health and disease: linking the microbiome-gut-brain Axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases","author":"Ghaisas","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2025.167862_bb0345","article-title":"Microbiota-gut-brain Axis and the central nervous system","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2025.167862_bb0350","doi-asserted-by":"crossref","unstructured":"Ullah, H.; Arbab, S.; Tian, Y.; Liu, C. Q.; Chen, Y.; Qijie, L.; Khan, M. I. U.; Hassan, I. U.; Li, K. The Gut Microbiota\u2013Brain Axis in Neurological Disorder. Front. Neurosci. 2023. doi:https:\/\/doi.org\/10.3389\/fnins.2023.1225875.","DOI":"10.3389\/fnins.2023.1225875"},{"key":"10.1016\/j.bbadis.2025.167862_bb0355","doi-asserted-by":"crossref","unstructured":"Morais, L. H.; Schreiber, H. L.; Mazmanian, S. K. The Gut Microbiota\u2013Brain Axis in Behaviour and Brain Disorders. Nat. Rev. Microbiol. 2021. doi:https:\/\/doi.org\/10.1038\/s41579-020-00460-0.","DOI":"10.1038\/s41579-020-00460-0"},{"key":"10.1016\/j.bbadis.2025.167862_bb0360","first-page":"28 (2)","article-title":"The gut-brain Axis: interactions between enteric microbiota, central and enteric nervous systems","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-31730-5","article-title":"Genetic correlations between Alzheimer\u2019s disease and gut microbiome genera","volume":"13","author":"Cammann","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167862_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110112","article-title":"Emerging role of gut microbiota in modulation of Neuroinflammation and neurodegeneration with emphasis on Alzheimer\u2019s disease","author":"Goyal","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2025.167862_bb0375","first-page":"27 (11)","article-title":"The role of microbiome in brain development and neurodegenerative diseases","author":"Nandwana","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2025.167862_bb0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-022-00681-2","article-title":"The microbiome\u2013gut\u2013brain Axis in Parkinson disease \u2014 from basic research to the clinic","author":"Tan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0385","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota Axis in Parkinson\u2019s disease","author":"Mulak","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0390","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","author":"Hou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.167862_bb0395","first-page":"298 (7)","article-title":"Mechanistic insights into accelerated \u03b1-Synuclein aggregation mediated by human microbiome-associated functional amyloids","author":"Bhoite","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167862_bb0400","article-title":"Gut microbiota: a novel therapeutic target for Parkinson\u2019s disease","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0405","article-title":"Gut microbiome Dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2025.167862_bb0410","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab156","article-title":"The role of gut Dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options","author":"Wang","year":"2021","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.bbadis.2025.167862_bb0415","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson\u2019s disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb0420","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-021-01066-7","article-title":"The gut-brain Axis: two ways signaling in Parkinson\u2019s disease","author":"Dogra","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2015.197","article-title":"Pathogenesis of Parkinson disease - the gut-brain Axis and environmental factors","author":"Klingelhoefer","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0430","doi-asserted-by":"crossref","DOI":"10.1002\/mdc3.12840","article-title":"Gut vibes in Parkinson\u2019s disease: the microbiota-gut-brain Axis","author":"Bullich","year":"2019","journal-title":"Movement Disorders Clinical Practice."},{"issue":"8","key":"10.1016\/j.bbadis.2025.167862_bb0435","article-title":"Role of the Vagus nerve in the gut-brain Axis: development and maintenance of gut regulatory T cells via the liver-brain-gut Vago-vagal reflex","volume":"74","author":"Kanai","year":"2022","journal-title":"Brain Nerve"},{"key":"10.1016\/j.bbadis.2025.167862_bb0440","first-page":"817","article-title":"Vagal pathways for microbiome-brain-gut Axis communication","author":"Forsythe","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0445","doi-asserted-by":"crossref","DOI":"10.2147\/JIR.S384949","article-title":"Vagus nerve and underlying impact on the gut microbiota-brain Axis in behavior and neurodegenerative diseases","author":"Han","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bbadis.2025.167862_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00049","article-title":"The Vagus nerve at the Interface of the microbiota-gut-brain Axis","author":"Bonaz","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0455","first-page":"105 (43)","article-title":"Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41","author":"Samuel","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbadis.2025.167862_bb0460","first-page":"292 (6)","article-title":"Enteroendocrine cells express functional toll-like receptors","author":"Bogunovic","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102171","article-title":"Does gut brain Axis has an impact on Parkinson\u2019s disease (PD)?","author":"Elangovan","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbadis.2025.167862_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1272955","article-title":"Enteroendocrine cell regulation of the gut-brain Axis","author":"Barton","year":"2023","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0475","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-017-0413-0","article-title":"Propagation of pathological \u03b1-Synuclein in marmoset brain","volume":"5","author":"Shimozawa","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2025.167862_bb0480","doi-asserted-by":"crossref","unstructured":"Hasegawa, M.; Nonaka, T.; Masuda-Suzukake, M. \u03b1-Synuclein: Experimental Pathology. Cold Spring Harb Perspect Med 2016, vol. 6 (9). doi:https:\/\/doi.org\/10.1101\/cshperspect.a024273.","DOI":"10.1101\/cshperspect.a024273"},{"key":"10.1016\/j.bbadis.2025.167862_bb0485","doi-asserted-by":"crossref","unstructured":"Masuda-Suzukake, M.; Nonaka, T.; Hosokawa, M.; Oikawa, T.; Arai, T.; Akiyama, H.; Mann, D. M. A.; Hasegawa, M. Prion-like spreading of pathological \u03b1-Synuclein in brain. Brain 2013, 136 (4). doi:https:\/\/doi.org\/10.1093\/brain\/awt037.","DOI":"10.1093\/brain\/awt037"},{"key":"10.1016\/j.bbadis.2025.167862_bb0490","first-page":"3","article-title":"Prion-like propagation of human brain-derived alpha-Synuclein in transgenic mice expressing human wild-type alpha-Synuclein","author":"Bernis","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2025.167862_bb0495","article-title":"Gut-to-brain \u03b1-Synuclein transmission in Parkinson\u2019s disease: evidence for prion-like mechanisms","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.01.012","article-title":"The prion-like spreading of \u03b1-Synuclein: from in vitro to in vivo models of Parkinson\u2019s disease","author":"Vargas","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbadis.2025.167862_bb0505","doi-asserted-by":"crossref","unstructured":"Breen, D. P.; Halliday, G. M.; Lang, A. E. Gut\u2013Brain Axis and the Spread of \u03b1-Synuclein Pathology: Vagal Highway or Dead End? Mov. Disord. 2019. doi:https:\/\/doi.org\/10.1002\/mds.27556.","DOI":"10.1002\/mds.27556"},{"key":"10.1016\/j.bbadis.2025.167862_bb0510","first-page":"125 (4)","article-title":"Activity-dependent secretion of alpha-Synuclein by enteric neurons","author":"Paillusson","year":"2013","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167862_bb0515","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1021\/acschembio.4c00095","article-title":"Discovery of a gut bacterial metabolic pathway that drives \u03b1-Synuclein aggregation","volume":"19","author":"Ortiz de Ora","year":"2024","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167862_bb0520","article-title":"\u0391-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease. JCI","volume":"2","author":"Chandra","year":"2017","journal-title":"Insight"},{"key":"10.1016\/j.bbadis.2025.167862_bb0525","doi-asserted-by":"crossref","unstructured":"Kakoty, V.; K C, S.; Dubey, S. K.; Yang, C. H.; Kesharwani, P.; Taliyan, R. The gut-brain connection in the pathogenicity of Parkinson disease: putative role of autophagy. Neurosci. Lett. 2021. doi:https:\/\/doi.org\/10.1016\/j.neulet.2021.135865.","DOI":"10.1016\/j.neulet.2021.135865"},{"key":"10.1016\/j.bbadis.2025.167862_bb0530","first-page":"78 (4)","article-title":"Vagotomy and subsequent risk of Parkinson\u2019s disease","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0535","first-page":"88 (21)","article-title":"Vagotomy and Parkinson disease a Swedish register-based matched-cohort study","author":"Liu","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167862_bb0540","article-title":"Vagus nerve and stomach Synucleinopathy in Parkinson\u2019s disease, incidental Lewy body disease, and Normal elderly subjects: evidence against the \u201cbody-first\u201d hypothesis","volume":"11","author":"Beach","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113573","article-title":"What is the evidence that Parkinson\u2019s disease is a prion disorder, which originates in the gut?","author":"Kujawska","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0550","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-191711","article-title":"Increasing comparability and utility of gut microbiome studies in Parkinson\u2019s disease: a systematic review","author":"Boertien","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb0555","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-016-0569-5","article-title":"Living together in biofilms: the microbial cell factory and its biotechnological implications","author":"Berlanga","year":"2016","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.bbadis.2025.167862_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02192","article-title":"Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms","author":"Gebreyohannes","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.bbadis.2025.167862_bb0565","doi-asserted-by":"crossref","unstructured":"Fulaz, S.; Vitale, S.; Quinn, L.; Casey, E. Nanoparticle\u2013Biofilm Interactions: The Role of the EPS Matrix. Trends Microbiol. 2019. doi:https:\/\/doi.org\/10.1016\/j.tim.2019.07.004.","DOI":"10.1016\/j.tim.2019.07.004"},{"key":"10.1016\/j.bbadis.2025.167862_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2020.03.016","article-title":"Biofilm Matrixome: extracellular components in structured microbial communities","author":"Karygianni","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0575","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-022-00791-0","article-title":"The biofilm matrix: multitasking in a shared space","author":"Flemming","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0580","doi-asserted-by":"crossref","unstructured":"Pirhaghi, M.; Najarzadeh, Z.; Moosavi-Movahedi, F.; Shafizadeh, M.; Mamashli, F.; Atarod, D.; Ghasemi, A.; Morshedi, D.; Meratan, A. A.; Otzen, D. E.; Saboury, A. A. The anti-platelet drug Ticlopidine inhibits FapC fibrillation and biofilm production: highlighting its antibiotic activity. Biochim. Biophys. Acta, Proteins Proteomics 2023, 1871 (2). doi:https:\/\/doi.org\/10.1016\/j.bbapap.2022.140883.","DOI":"10.1016\/j.bbapap.2022.140883"},{"key":"10.1016\/j.bbadis.2025.167862_bb0585","doi-asserted-by":"crossref","DOI":"10.1038\/ijos.2014.65","article-title":"Strategies for combating bacterial biofilm infections","author":"Wu","year":"2015","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0590","first-page":"102 (17)","article-title":"Protein fibrils in nature can enhance amyloid protein a amyloidosis in mice: cross-seeding as a disease mechanism","author":"Lundmark","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0595","doi-asserted-by":"crossref","DOI":"10.5056\/jnm18087","article-title":"Brain-gut-microbiota Axis in Alzheimer\u2019s disease","volume":"25","author":"Kowalski","year":"2019","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.bbadis.2025.167862_bb0600","first-page":"15 (8)","article-title":"Structural insights into Curli CsgA cross-\u03b2 fibril architecture inspire repurposing of anti-amyloid compounds as anti-biofilm agents","author":"Perov","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbadis.2025.167862_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118627","article-title":"Role of gut-brain Axis, gut microbial composition, and probiotic intervention in Alzheimer\u2019s disease","author":"Kesika","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0610","first-page":"269","article-title":"Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology","author":"Ivanova","year":"2021","journal-title":"Biophys. Chem."},{"issue":"9","key":"10.1016\/j.bbadis.2025.167862_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113071","article-title":"Fiber deprivation and microbiome-borne Curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson\u2019s disease","volume":"42","author":"Schmit","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2025.167862_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638867","article-title":"Microbiome or infections: amyloid-containing biofilms as a trigger for complex human diseases","author":"Miller","year":"2021","journal-title":"Front. Immunol."},{"issue":"29","key":"10.1016\/j.bbadis.2025.167862_bb0625","article-title":"Alzheimer\u2019s progenitor amyloid-\u03b2 targets and dissolves microbial amyloids and impairs biofilm function. Advanced","volume":"10","author":"Ali","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167862_bb0630","doi-asserted-by":"crossref","unstructured":"Kumar, D. K. V.; Choi, H. S.; Washicosky, K. J.; Eimer, W. A.; Tucker, S.; Ghofrani, J.; Lefkowitz, A.; McColl, G.; Goldstein, L. E.; Tanzi, R. E.; Moir, R. D. Amyloid-\u03b2 Peptide Protects against Microbial Infection in Mouse and Worm Models of Alzheimer's Disease. Sci Transl Med 2016, 8 (340). doi:https:\/\/doi.org\/10.1126\/scitranslmed.aaf1059.","DOI":"10.1126\/scitranslmed.aaf1059"},{"key":"10.1016\/j.bbadis.2025.167862_bb0635","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.micro.60.080805.142106","article-title":"Curli biogenesis and function","author":"Barnhart","year":"2006","journal-title":"Ann. Rev. Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0640","doi-asserted-by":"crossref","unstructured":"Christensen, L. F. B.; Schafer, N.; Wolf-Perez, A.; Madsen, D. J.; Otzen, D. E. Bacterial Amyloids: Biogenesis and Biomaterials. In Advances in Experimental Medicine and Biology; 2019; Vol. 1174. doi:https:\/\/doi.org\/10.1007\/978-981-13-9791-2_4.","DOI":"10.1007\/978-981-13-9791-2_4"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0645","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14145-7","article-title":"Assembly and substrate recognition of Curli biogenesis system","volume":"11","author":"Yan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2025.167862_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2018.07.007","article-title":"Amyloid by design: intrinsic regulation of microbial amyloid assembly","author":"Deshmukh","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0655","doi-asserted-by":"crossref","unstructured":"Wang, X.; Zhou, Y.; Ren, J. J.; Hammer, N. D.; Chapman, M. R. Gatekeeper residues in the major Curlin subunit modulate bacterial amyloid Fiber biogenesis. Proc. Natl. Acad. Sci. USA 2010, 107 (1). doi:https:\/\/doi.org\/10.1073\/pnas.0908714107.","DOI":"10.1073\/pnas.0908714107"},{"key":"10.1016\/j.bbadis.2025.167862_bb0660","doi-asserted-by":"crossref","unstructured":"Wang, X.; Hammer, N. D.; Chapman, M. R. The molecular basis of functional bacterial amyloid polymerization and nucleation. J. Biol. Chem. 2008, 283 (31). doi:https:\/\/doi.org\/10.1074\/jbc.M800466200.","DOI":"10.1074\/jbc.M800466200"},{"key":"10.1016\/j.bbadis.2025.167862_bb0665","first-page":"282 (6)","article-title":"In vitro polymerization of a functional Escherichia Coli amyloid protein","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167862_bb0670","first-page":"352 (2)","article-title":"The formation of Escherichia Coli Curli amyloid fibrils is mediated by prion-like peptide repeats","author":"Cherny","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0675","first-page":"9","article-title":"A gut bacterial amyloid promotes A-Synuclein aggregation and motor impairment in mice","author":"Sampson","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.bbadis.2025.167862_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2021.07.009","article-title":"Gut power: modulation of human amyloid formation by Amyloidogenic proteins in the gastrointestinal tract","author":"Wittung-Stafshede","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167862_bb0685","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1134\/S0006297924030118","article-title":"Role of the gut microbiome and bacterial amyloids in the development of Synucleinopathies","volume":"89","author":"Trubitsina","year":"2024","journal-title":"Biochem. Mosc."},{"key":"10.1016\/j.bbadis.2025.167862_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134080","article-title":"Functional bacterial amyloids: understanding fibrillation, regulating biofilm fibril formation and organizing surface assemblies","author":"S\u00f8nderby","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2025.167862_bb0695","author":"Matilla-Cuenca","year":"2021","journal-title":"Anti-Biofilm Molecules Targeting Functional Amyloids. Antibiotics."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167862_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8121951","article-title":"Functional amyloids are the rule rather than the exception in cellular biology","volume":"8","author":"Balistreri","year":"2020","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167862_bb0705","article-title":"Reducing the Amyloidogenicity of functional amyloid protein FapC increases its ability to inhibit \u03b1-Synuclein fibrillation. ACS","volume":"4","author":"Christensen","year":"2019","journal-title":"Omega"},{"issue":"18","key":"10.1016\/j.bbadis.2025.167862_bb0710","article-title":"Accelerated amyloid Beta pathogenesis by bacterial amyloid FapC. Advanced","volume":"7","author":"Javed","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0715","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00628-1","article-title":"Overexpression of human alpha-Synuclein leads to dysregulated microbiome\/metabolites with ageing in a rat model of Parkinson disease","volume":"18","author":"Singh","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.bbadis.2025.167862_bb0720","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4137","article-title":"Identification of Amyloidogenic proteins in the microbiomes of a rat Parkinson\u2019s disease model and wild-type rats","volume":"30","author":"Christensen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0725","article-title":"Young rat microbiota extracts strongly inhibit fibrillation of \u03b1-Synuclein and protect neuroblastoma cells and zebrafish against \u03b1-Synuclein toxicity","author":"Shiraz","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2025.167862_bb0730","first-page":"13","article-title":"Integrated microbiome and host transcriptome profiles link Parkinson\u2019s disease to Blautia genus: evidence from feces, blood, and brain","author":"Guo","year":"2022","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167862_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002744","article-title":"Functional amyloids composed of phenol soluble Modulins stabilize staphylococcus aureus biofilms","volume":"8","author":"Schwartz","year":"2012","journal-title":"PLoS Pathog."},{"issue":"21","key":"10.1016\/j.bbadis.2025.167862_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111594","article-title":"The bacterial amyloids phenol soluble Modulins from staphylococcus aureus catalyze alpha-Synuclein aggregation","volume":"22","author":"Haikal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0745","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-024-02769-z","article-title":"Parkinson\u2019s disease and vitamins: a focus on vitamin B12","author":"Rekik","year":"2024","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2025.167862_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2019.11.005","article-title":"Vitamins for the gut microbiome","author":"Steinert","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2025.167862_bb0755","doi-asserted-by":"crossref","unstructured":"Zhai, Z.; Dong, W.; Sun, Y.; Gu, Y.; Ma, J.; Wang, B.; Cao, H. Vitamin\u2013Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis. Nutrients. 2022. doi:https:\/\/doi.org\/10.3390\/nu14163383.","DOI":"10.3390\/nu14163383"},{"key":"10.1016\/j.bbadis.2025.167862_bb0760","doi-asserted-by":"crossref","DOI":"10.1080\/10408398.2020.1793728","article-title":"Metabolic and functional interplay between gut microbiota and fat-soluble vitamins","author":"Stacchiotti","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bbadis.2025.167862_bb0765","doi-asserted-by":"crossref","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2025.167862_bb0770","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10061168","article-title":"B vitamins and their roles in gut health","author":"Hossain","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.bbadis.2025.167862_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202000426","article-title":"Functional roles of B-vitamins in the gut and gut microbiome","author":"Uebanso","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbadis.2025.167862_bb0780","doi-asserted-by":"crossref","DOI":"10.1097\/00008469-199703001-00009","article-title":"Intestinal Flora and Endogenous vitamin synthesis. In","volume":"6","author":"Hill","year":"1997","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.bbadis.2025.167862_bb0785","doi-asserted-by":"crossref","unstructured":"Yan, H.; Chen, Y.; Zhu, H.; Huang, W. H.; Cai, X. H.; Li, D.; Lv, Y. J.; Si-Zhao; Zhou, H. H.; Luo, F. Y.; Zhang, W.; Li, X. The relationship among intestinal Bacteria, vitamin K and response of vitamin K antagonist: A Review of Evidence and Potential Mechanism. Frontiers in Medicine. 2022. doi:https:\/\/doi.org\/10.3389\/fmed.2022.829304.","DOI":"10.3389\/fmed.2022.829304"},{"key":"10.1016\/j.bbadis.2025.167862_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1031502","article-title":"Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health","author":"Wan","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bbadis.2025.167862_bb0795","first-page":"28 (S4)","article-title":"Role of the gut microbiota in human nutrition and metabolism","author":"Ramakrishna","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology (Australia)"},{"key":"10.1016\/j.bbadis.2025.167862_bb0800","doi-asserted-by":"crossref","unstructured":"Sandeep; Sahu, M. R.; Rani, L.; Kharat, A. S.; Mondal, A. C. Could vitamins have a positive impact on the treatment of Parkinson's disease? Brain Sci. 2023. doi:https:\/\/doi.org\/10.3390\/brainsci13020272.","DOI":"10.3390\/brainsci13020272"},{"issue":"9","key":"10.1016\/j.bbadis.2025.167862_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/nu7095333","article-title":"Associations between B vitamins and Parkinson\u2019s disease","volume":"7","author":"Shen","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2025.167862_bb0810","article-title":"Benefits of vitamins in the treatment of Parkinson\u2019s disease","author":"Zhao","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0815","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-022-01298-9","article-title":"Metagenomic insights into the microbe-mediated B and K2 vitamin biosynthesis in the gastrointestinal microbiome of ruminants","volume":"10","author":"Jiang","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.bbadis.2025.167862_bb0820","first-page":"278 (42)","article-title":"The Phosphonopyruvate decarboxylase from Bacteroides Fragilis","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167862_bb0825","doi-asserted-by":"crossref","unstructured":"Magn\u00fasd\u00f3ttir, S.; Ravcheev, D.; De Cr\u00e9cy-Lagard, V.; Thiele, I. Systematic Genome Assessment of B-Vitamin Biosynthesis Suggests Cooperation among Gut Microbes. Front Genet 2015, 6 (MAR). doi:https:\/\/doi.org\/10.3389\/fgene.2015.00148.","DOI":"10.3389\/fgene.2015.00148"},{"key":"10.1016\/j.bbadis.2025.167862_bb0830","first-page":"339","article-title":"Dysbiosis of gut microbiota in patients with Neuromyelitis Optica Spectrum disorders: a cross sectional study","author":"Shi","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0835","first-page":"9","article-title":"Proteomics of Porphyromonas Gingivalis within a model Oral microbial community","author":"Kuboniwa","year":"2009","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0840","doi-asserted-by":"crossref","unstructured":"Soto-Martin, E. C.; Warnke, I.; Farquharson, F. M.; Christodoulou, M.; Horgan, G.; Derrien, M.; Faurie, J. M.; Flint, H. J.; Duncan, S. H.; Louis, P. Vitamin biosynthesis by human gut butyrate-producing Bacteria and cross-feeding in synthetic microbial communities. mBio 2020, 11 (4). doi:https:\/\/doi.org\/10.1128\/mBio.00886-20.","DOI":"10.1128\/mBio.00886-20"},{"issue":"C","key":"10.1016\/j.bbadis.2025.167862_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/S0083-6729(08)60684-6","article-title":"Pantothenic acid in health and disease","volume":"46","author":"Tahiliani","year":"1991","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bbadis.2025.167862_bb0850","article-title":"The biosynthesis of coenzyme a in Bacteria","author":"Begley","year":"2001","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bbadis.2025.167862_bb0855","first-page":"185 (18)","article-title":"Lactobacillus Reuteri CRL1098 produces cobalamin","author":"Taranto","year":"2003","journal-title":"J. Bacteriol."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167862_bb0860","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02719-07","article-title":"High-level Folate production in fermented foods by the B12 producer lactobacillus Reuteri JCM1112","volume":"74","author":"Santos","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0865","first-page":"206","article-title":"Enhancing vitamin B12 content in soy-yogurt by lactobacillus Reuteri","author":"Gu","year":"2015","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0870","doi-asserted-by":"crossref","unstructured":"Li, P.; Gu, Q.; Wang, Y.; Yu, Y.; Yang, L.; Chen, J. V. Novel vitamin B12-producing Enterococcus Spp. and preliminary in vitro evaluation of probiotic potentials. Appl. Microbiol. Biotechnol. 2017, 101 (15). doi:https:\/\/doi.org\/10.1007\/s00253-017-8373-7.","DOI":"10.1007\/s00253-017-8373-7"},{"key":"10.1016\/j.bbadis.2025.167862_bb0875","doi-asserted-by":"crossref","unstructured":"Sriramulu, D. D.; Liang, M.; Hernandez-Romero, D.; Raux-Deery, E.; L\u00fcnsdorf, H.; Parsons, J. B.; Warren, M. J.; Prentice, M. B. Lactobacillus Reuteri DSM 20016 produces cobalamin-dependent diol dehydratase in Metabolosomes and metabolizes 1,2-Propanediol by disproportionation. J. Bacteriol. 2008, 190 (13). doi:https:\/\/doi.org\/10.1128\/JB.01535-07.","DOI":"10.1128\/JB.01535-07"},{"key":"10.1016\/j.bbadis.2025.167862_bb0880","doi-asserted-by":"crossref","unstructured":"Wibowo, S.; Pramadhani, A. Vitamin B, Role of Gut Microbiota and Gut Health. In Vitamin B and Vitamin E - Pleiotropic and Nutritional Benefits; IntechOpen, 2024. doi:https:\/\/doi.org\/10.5772\/intechopen.109485.","DOI":"10.5772\/intechopen.109485"},{"key":"10.1016\/j.bbadis.2025.167862_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2019.00048","article-title":"Metabolism of dietary and microbial vitamin b family in the regulation of host immunity","author":"Yoshii","year":"2019","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bbadis.2025.167862_bb0890","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171148","article-title":"Thiamine and selected thiamine antivitamins \u2014 biological activity and methods of synthesis","author":"Tylicki","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbadis.2025.167862_bb0895","first-page":"271 (1)","article-title":"Cerebrospinal fluid levels of thiamine in patients with Parkinson\u2019s disease","author":"Jim\u00e9nez-Jim\u00e9nez","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2025.167862_bb0900","article-title":"Thiamine deficiency and neurodegeneration: the interplay among oxidative stress, endoplasmic reticulum stress, and autophagy","author":"Liu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2025.167862_bb0905","doi-asserted-by":"crossref","DOI":"10.1111\/cns.12078","article-title":"The beneficial role of thiamine in Parkinson disease","author":"Luong","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167862_bb0910","doi-asserted-by":"crossref","DOI":"10.1097\/NEN.0000000000000017","article-title":"Thiamine deficiency induces massive cell death in the olfactory bulbs of mice","volume":"72","author":"Hamada","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb0915","doi-asserted-by":"crossref","DOI":"10.1038\/ejcn.2016.181","article-title":"Intake of vitamin B before onset of Parkinson\u2019s disease and atypical parkinsonism and olfactory function at the time of diagnosis","volume":"71","author":"H\u00e5glin","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2025.167862_bb0920","first-page":"37","article-title":"Low plasma thiamine and phosphate in male patients with Parkinson\u2019s disease is associated with mild cognitive impairment","author":"H\u00e5glin","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.bbadis.2025.167862_bb0925","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/B978-0-323-95735-9.00015-2","article-title":"Neuroprotective abilities of vitamins, micronutrients, antioxidants, and nutraceuticals","author":"Adhikary","year":"2024","journal-title":"In A Review on Diverse Neurological Disorders; Elsevier"},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2025.167862_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.02.008","article-title":"Thiamine and Parkinson\u2019s disease","volume":"316","author":"L\u01b0\u01a1ng","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0935","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009289","article-title":"High-dose thiamine as initial treatment for Parkinson\u2019s disease","author":"Costantini","year":"2013","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.bbadis.2025.167862_bb0940","first-page":"174","article-title":"4,4\u2032-Dimethoxychalcone regulates redox homeostasis by targeting riboflavin metabolism in Parkinson\u2019s disease therapy","author":"Gong","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2025.167862_bb0945","doi-asserted-by":"crossref","DOI":"10.1007\/s40261-021-01038-1","article-title":"Riboflavin in neurological diseases: a narrative review","author":"Plantone","year":"2021","journal-title":"Clin. Drug Investig."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167862_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/S0955-2863(02)00207-3","article-title":"Assessment of the relationship between the Antimutagenic action of riboflavin and glutathione and the levels of antioxidant enzymes","volume":"13","author":"Durusoy","year":"2002","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbadis.2025.167862_bb0955","doi-asserted-by":"crossref","DOI":"10.1111\/cen3.12553","article-title":"Niacin for Parkinson\u2019s disease","author":"Seamon","year":"2020","journal-title":"Clinical and Experimental Neuroimmunology."},{"key":"10.1016\/j.bbadis.2025.167862_bb0960","doi-asserted-by":"crossref","DOI":"10.1265\/ehpm.10.3","article-title":"Niacin metabolism and Parkinson\u2019s disease","author":"Fukushima","year":"2005","journal-title":"Environ. Health Prev. Med."},{"issue":"18","key":"10.1016\/j.bbadis.2025.167862_bb0965","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184559","article-title":"Niacin ameliorates neuro-inflammation in Parkinson\u2019s disease via GPR109A","volume":"20","author":"Giri","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0970","doi-asserted-by":"crossref","unstructured":"Motawi, T. K.; Sadik, N. A. H.; Hamed, M. A.; Ali, S. A.; Khalil, W. K. B.; Ahmed, Y. R. Potential Therapeutic Effects of Antagonizing Adenosine A2A Receptor, Curcumin and Niacin in Rotenone-Induced Parkinson's Disease Mice Model. Mol Cell Biochem 2020, 465 (1\u20132). doi:https:\/\/doi.org\/10.1007\/s11010-019-03670-0.","DOI":"10.1007\/s11010-019-03670-0"},{"key":"10.1016\/j.bbadis.2025.167862_bb0975","first-page":"13","article-title":"Niacin enhancement for Parkinson\u2019s disease: An effectiveness trial","author":"Chong","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0980","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/10284150500484638","article-title":"Niacin improved rigidity and bradykinesia in a Parkinson\u2019s disease patient but also caused unacceptable nightmares and skin rash - a case report","volume":"8","author":"Alisky","year":"2005","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb0985","doi-asserted-by":"crossref","unstructured":"Xin, C.; Yang, N.; Ding, Y.; Han, L.; Zhou, Z.; Guo, X.; Fang, Z.; Bai, H.; Peng, B.; Zhang, C.; Li, L. Mitochondrial-Targeting Vitamin B3 Ameliorates the Phenotypes of Parkinson's Disease In Vitro and In Vivo by Restoring Mitochondrial Function. Adv Ther (Weinh) 2022, 5 (12). doi:https:\/\/doi.org\/10.1002\/adtp.202200094.","DOI":"10.1002\/adtp.202200094"},{"issue":"9","key":"10.1016\/j.bbadis.2025.167862_bb0990","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.21650","article-title":"High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson\u2019s disease","volume":"86","author":"Jia","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167862_bb0995","article-title":"Enhancing NAD+ salvage metabolism is neuroprotective in a PINK1 model of Parkinson\u2019s disease","volume":"6","author":"Lehmann","year":"2017","journal-title":"Biol Open"},{"key":"10.1016\/j.bbadis.2025.167862_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2014.10.024","article-title":"A novel treatment target for Parkinson\u2019s disease","author":"Wakade","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1005","first-page":"320","article-title":"Niacin modulates macrophage polarization in Parkinson\u2019s disease","author":"Wakade","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2025.167862_bb1010","article-title":"Niacin and butyrate: nutraceuticals targeting Dysbiosis and intestinal permeability in Parkinson\u2019s disease","author":"Karunaratne","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2025.167862_bb1015","first-page":"277 (24)","article-title":"Complete reconstitution of the human coenzyme a biosynthetic pathway via comparative genomics","author":"Daugherty","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167862_bb1020","first-page":"15 (1)","article-title":"Acetyl-CoA metabolism in cholinergic neurons and their susceptibility to neurotoxic inputs","author":"Szutowicz","year":"2000","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167862_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2011.05.004","article-title":"Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes","volume":"42","author":"Cai","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2025.167862_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","author":"Shi","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167862_bb1035","first-page":"268 (34)","article-title":"Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart","author":"Saddik","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167862_bb1040","article-title":"Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation","volume":"42","author":"Alrob","year":"2014","journal-title":"In Biochemical Society Transactions"},{"key":"10.1016\/j.bbadis.2025.167862_bb1045","doi-asserted-by":"crossref","unstructured":"Scholefield, M.; Church, S. J.; Xu, J.; Patassini, S.; Hooper, N. M.; Unwin, R. D.; Cooper, G. J. S. Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson's Disease Dementia. Metabolites 2021, 11 (9). doi:https:\/\/doi.org\/10.3390\/metabo11090569.","DOI":"10.3390\/metabo11090569"},{"key":"10.1016\/j.bbadis.2025.167862_bb1050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225797","article-title":"B vitamins and fatty acids: what Do they share with small vessel disease-related dementia?","author":"Moretti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167862_bb1055","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9060113","article-title":"Cerebral vitamin B5 (D-pantothenic acid) deficiency as a potential cause of metabolic perturbation and neurodegeneration in Huntington\u2019s disease","volume":"9","author":"Patassini","year":"2019","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167862_bb1060","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3233\/JPD-240075","article-title":"Localized pantothenic acid (vitamin B5) reductions present throughout the dementia with Lewy bodies brain","volume":"14","author":"Scholefield","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb1065","doi-asserted-by":"crossref","unstructured":"Vascellari, S.; Palmas, V.; Melis, M.; Pisanu, S.; Cusano, R.; Uva, P.; Perra, D.; Madau, V.; Sarchioto, M.; Oppo, V.; Simola, N.; Morelli, M.; Santoru, M. L.; Atzori, L.; Melis, M.; Cossu, G.; Manzin, A. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease. mSystems 2020, 5 (5). doi:https:\/\/doi.org\/10.1128\/msystems.00561-20.","DOI":"10.1128\/mSystems.00561-20"},{"key":"10.1016\/j.bbadis.2025.167862_bb1070","doi-asserted-by":"crossref","DOI":"10.1002\/biof.5520170107","article-title":"Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals - the role of glutathione. In","volume":"17","author":"Wojtczak","year":"2003","journal-title":"BioFactors"},{"key":"10.1016\/j.bbadis.2025.167862_bb1075","first-page":"33 (3)","article-title":"Curative role of pantothenic acid in brain damage of gamma irradiated rats","author":"Sm","year":"2018","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.bbadis.2025.167862_bb1080","doi-asserted-by":"crossref","unstructured":"Slyshenkov, V. S.; Dymkowska, D.; Wojtczak, L. Pantothenic acid and Pantothenol increase biosynthesis of glutathione by boosting cell energetics. FEBS Lett. 2004, 569 (1\u20133). doi:https:\/\/doi.org\/10.1016\/j.febslet.2004.05.044.","DOI":"10.1016\/j.febslet.2004.05.044"},{"key":"10.1016\/j.bbadis.2025.167862_bb1085","doi-asserted-by":"crossref","unstructured":"Jung, S.; Kim, M. K.; Choi, B. Y. The long-term relationship between dietary pantothenic acid (vitamin B5) intake and C-reactive protein concentration in adults aged 40 years and older. Nutr. Metab. Cardiovasc. Dis. 2017, 27 (9). doi:https:\/\/doi.org\/10.1016\/j.numecd.2017.05.008.","DOI":"10.1016\/j.numecd.2017.05.008"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1090","doi-asserted-by":"crossref","DOI":"10.1134\/S1819712421010128","article-title":"Modulating oxidative stress indices and thiol-disulfide balance in the brain structures by pantothenic acid derivatives in an experimental model of Parkinson\u2019s disease","volume":"15","author":"Semenovich","year":"2021","journal-title":"Neurochem. J."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1095","article-title":"Pantothenate kinase 2 interacts with PINK1 to regulate mitochondrial quality control via acetyl-CoA metabolism","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2025.167862_bb1100","doi-asserted-by":"crossref","DOI":"10.1002\/mdc3.12688","article-title":"Levodopa-induced neuropathy: a systematic review","author":"Romagnolo","year":"2019","journal-title":"Movement Disorders Clinical Practice."},{"key":"10.1016\/j.bbadis.2025.167862_bb1105","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010228","article-title":"Vitamins and minerals for energy, fatigue and cognition: a narrative review of the biochemical and clinical evidence","author":"Tardy","year":"2020","journal-title":"Nutrients"},{"issue":"24","key":"10.1016\/j.bbadis.2025.167862_bb1110","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.9577-22","article-title":"Vitamin B6 deficiency Anemia attributed to levodopa\/ carbidopa intestinal gel therapy for Parkinson\u2019s disease: a diagnostic pitfall for myelodysplastic syndrome with ring Sideroblasts","volume":"61","author":"Yasuda","year":"2022","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbadis.2025.167862_bb1115","doi-asserted-by":"crossref","DOI":"10.1097\/CND.0000000000000049","article-title":"Revisiting the evidence for neuropathy caused by pyridoxine deficiency and excess","author":"Ghavanini","year":"2014","journal-title":"J. Clin. Neuromuscul. Dis."},{"issue":"22","key":"10.1016\/j.bbadis.2025.167862_bb1120","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e31823a0ee4","article-title":"Neuropathy in Parkinson disease prevalence and determinants","volume":"77","author":"Rajabally","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2025.167862_bb1125","first-page":"88 (8)","article-title":"Prevalence of epilepsy\/seizures as a comorbidity of neurologic disorders in nursing homes","author":"Birnbaum","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2025.167862_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120028","article-title":"Neuropathy due to coexistent vitamin B12 and B6 deficiencies in patients with Parkinson\u2019s disease: a case series","author":"Canissario","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120690","article-title":"A systematic review of the potential consequences of abnormal serum levels of vitamin B6 in people living with Parkinson\u2019s disease","author":"Modica","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1140","doi-asserted-by":"crossref","unstructured":"Torres, M.; Zhang, X.; Christine, C.; Bjornevik, K.; Hung, A.; Schwarzschild, M.; Ascherio, A. Intake of B vitamins and the risk of death among individuals with Parkinson's disease (P11-3.018). Neurology 2024, 102 (17_supplement_1). doi:https:\/\/doi.org\/10.1212\/WNL.0000000000205703.","DOI":"10.1212\/WNL.0000000000205703"},{"key":"10.1016\/j.bbadis.2025.167862_bb1145","doi-asserted-by":"crossref","unstructured":"Song, I. U.; Kim, J. S.; Park, I. S.; Kim, Y. Do; Cho, H. J.; Chung, S. W.; Lee, K. S. Clinical significance of homocysteine (Hcy) on dementia in Parkinson's disease (PD). Arch. Gerontol. Geriatr. 2013, 57 (3). doi:https:\/\/doi.org\/10.1016\/j.archger.2013.04.015.","DOI":"10.1016\/j.archger.2013.04.015"},{"key":"10.1016\/j.bbadis.2025.167862_bb1150","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1254824","article-title":"Association between the risk and severity of Parkinson\u2019s disease and plasma homocysteine, vitamin B12 and Folate levels: a systematic review and Meta-analysis","author":"Quan","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1155","first-page":"17 (3)","article-title":"Elevated homocysteine levels in Parkinsons disease: is there anything besides L-Dopa treatment?","author":"Zoccolella","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.167862_bb1160","doi-asserted-by":"crossref","unstructured":"Wei, Z.; Tiandong, W.; Yang, L.; Huaxing, M.; Guowen, M.; Yalan, F.; Xiaoyuan, N. Parkinson's disease and homocysteine: a community-based study in a Folate and vitamin B12 deficient population. Parkinsons Dis 2016, 2016. doi:https:\/\/doi.org\/10.1155\/2016\/9539836.","DOI":"10.1155\/2016\/9539836"},{"issue":"11","key":"10.1016\/j.bbadis.2025.167862_bb1165","article-title":"The effect of levodopa Benserazide hydrochloride on Homocysteinemia levels in patients with Parkinson\u2019s disease and treatment of Hyperhomocysteinemia","volume":"20","author":"Guo","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1170","first-page":"24 (9)","article-title":"Homocysteine levels after acute levodopa intake in patients with Parkinson\u2019s disease","author":"M\u00fcller","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2008.10.005","article-title":"Effect of levodopa and Entacapone treatment on plasma homocysteine levels in Parkinson\u2019s disease patients","author":"Nevrly","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1180","first-page":"11 (4)","article-title":"Reduced plasma homocysteine levels in levodopa\/Entacapone treated Parkinson patients","author":"Valkovi\u010d","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1185","doi-asserted-by":"crossref","DOI":"10.1002\/mds.20261","article-title":"Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson\u2019s disease patients","volume":"20","author":"Lamberti","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1190","doi-asserted-by":"crossref","DOI":"10.1034\/j.1600-0404.2003.00135.x","article-title":"Levodopa-induced Hyperhomocysteinaemia in Parkinson\u2019s disease","author":"Yasui","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbadis.2025.167862_bb1195","doi-asserted-by":"crossref","DOI":"10.1159\/000525234","article-title":"Refractory seizures secondary to vitamin B6 deficiency in Parkinson disease: the role of carbidopa-levodopa","author":"Wise","year":"2022","journal-title":"Case Rep Neurol"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167862_bb1200","doi-asserted-by":"crossref","DOI":"10.1097\/WNF.0000000000000408","article-title":"Vitamin B6 deficiency in patients with Parkinson disease treated with levodopa\/carbidopa","volume":"43","author":"Rojo-Sebasti\u00e1n","year":"2020","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.bbadis.2025.167862_bb1205","first-page":"94 (24)","article-title":"Pearls and oy-Sters: vitamin B6deficiency presenting with new-onset epilepsy and status epilepticus in a patient with Parkinson disease","author":"Modica","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2025.167862_bb1210","series-title":"Vitamins and Minerals in Neurological Disorders","first-page":"527","article-title":"B vitamins: Pyridoxal phosphate and parkinsonism","author":"Onaolapo","year":"2023"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1215","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1174","article-title":"Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson\u2019s disease patients","volume":"12","author":"Ikenaka","year":"2024","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbadis.2025.167862_bb1220","first-page":"67 (2)","article-title":"Vitamin B12, and vitamin B6 and the risk of Parkinson disease","author":"De Lau","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2025.167862_bb1225","first-page":"460 (3)","article-title":"Folic acid supplementation rescues anomalies associated with knockdown of Parkin in dopaminergic and serotonergic neurons in Drosophila model of Parkinson\u2019s disease","author":"Srivastav","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2025.167862_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","author":"Mattson","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1235","first-page":"14","article-title":"Serum vitamin levels in multiple system atrophy: a case-control study","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167862_bb1240","doi-asserted-by":"crossref","DOI":"10.1038\/ncb2901","article-title":"Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson\u2019s disease","volume":"16","author":"Tufi","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167862_bb1245","first-page":"40 (7)","article-title":"Folic acid supplementation ameliorates oxidative stress, metabolic functions and developmental anomalies in a novel Fly model of Parkinson\u2019s disease","author":"Srivastav","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2025.167862_bb1250","doi-asserted-by":"crossref","unstructured":"Finkelstein, J. D. The Metabolism of Homocysteine: Pathways and Regulation. European Journal of Pediatrics, Supplement 1998, 157 (2). doi:https:\/\/doi.org\/10.1007\/pl00014300.","DOI":"10.1007\/PL00014300"},{"key":"10.1016\/j.bbadis.2025.167862_bb1255","first-page":"94 (6)","article-title":"Exfoliation syndrome: assembling the puzzle pieces","author":"Pasquale","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.bbadis.2025.167862_bb1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105587","article-title":"Plasma homocysteine, Folate and vitamin B12 levels in Parkinson\u2019s disease in China: a Meta-analysis","author":"Dong","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167862_bb1265","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-018-3480-5","article-title":"Hyperhomocysteinemia influenced malnutrition in Parkinson\u2019s disease patients","volume":"39","author":"Tomic","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1270","doi-asserted-by":"crossref","DOI":"10.1177\/0891988716673466","article-title":"Efficacy of vitamin B supplementation on cognition in elderly patients with cognitive-related diseases: a systematic review and Meta-analysis","author":"Zhang","year":"2017","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.bbadis.2025.167862_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105357","article-title":"Levodopa, homocysteine and Parkinson\u2019s disease: what\u2019s the problem?","author":"Ahlskog","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1280","first-page":"88","article-title":"Effects of vitamin B12, Folate, and Entacapone on homocysteine levels in levodopa-treated Parkinson\u2019s disease patients: a randomized controlled study","author":"Anamnart","year":"2021","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1285","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-023-02684-9","article-title":"Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson\u2019s disease: clinical and therapeutic considerations","author":"Phokaewvarangkul","year":"2023","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbadis.2025.167862_bb1290","doi-asserted-by":"crossref","unstructured":"Li, S.; Zhang, Q.; Gao, Y.; Nie, K.; Liang, Y.; Zhang, Y.; Wang, L. Serum Folate, Vitamin B12 levels, and systemic immune-inflammation index correlate with motor performance in Parkinson's disease: a cross-sectional study. Front. Neurol. 2021, 12. doi:https:\/\/doi.org\/10.3389\/fneur.2021.665075.","DOI":"10.3389\/fneur.2021.665075"},{"key":"10.1016\/j.bbadis.2025.167862_bb1295","doi-asserted-by":"crossref","unstructured":"Qureshi, G.; Qureshi, A.; Devrajani, B.; Chippa, M.; Syed, S. Is the Deficiency of Vitamin B12 Related to Oxidative Stress and Neurotoxicity in Parkinsons Patients? CNS Neurol Disord Drug Targets 2008, 7 (1). doi:https:\/\/doi.org\/10.2174\/187152708783885101.","DOI":"10.2174\/187152708783885101"},{"issue":"15","key":"10.1016\/j.bbadis.2025.167862_bb1300","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3390\/diagnostics14151609","article-title":"The impact of the dietary intake of vitamin B12, folic acid, and vitamin D3 on homocysteine levels and the health-related quality of life of levodopa-treated patients with Parkinson\u2019s disease\u2014a pilot study in Romania","volume":"14","author":"Turcu-Stiolica","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbadis.2025.167862_bb1305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000333790","article-title":"Effects of exercise and B vitamins on homocysteine and glutathione in Parkinson\u2019s disease: a randomized trial","volume":"10","author":"DiFrancisco-Donoghue","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbadis.2025.167862_bb1310","first-page":"66 (12)","article-title":"Vitamins and Entacapone in levodopa-induced Hyperhomocysteinemia: a randomized controlled study","author":"Postuma","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2025.167862_bb1315","first-page":"17 (5)","article-title":"Hyperhomocysteinemia recurrence in levodopa-treated Parkinson\u2019s disease patients","author":"Belcastro","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167862_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2007.10.002","article-title":"Folate and vitamin B12 levels in levodopa-treated Parkinson\u2019s disease patients: their relationship to clinical manifestations, mood and cognition","volume":"14","author":"Triantafyllou","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1325","doi-asserted-by":"crossref","unstructured":"Rajabally, Y. A.; Martey, J. Levodopa, Vitamins, ageing and the neuropathy of Parkinson's disease. J. Neurol. 2013, 260 (11). doi:https:\/\/doi.org\/10.1007\/s00415-013-7079-8.","DOI":"10.1007\/s00415-013-7079-8"},{"key":"10.1016\/j.bbadis.2025.167862_bb1330","doi-asserted-by":"crossref","DOI":"10.31083\/j.jin2205115","article-title":"Features of plasma homocysteine, vitamin B12, and Folate in Parkinson\u2019s disease: An updated Meta-analysis","author":"Liu","year":"2023","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1335","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10060871","article-title":"Effects of folic acid supplementation on oxidative stress markers: a systematic review and Meta-analysis of randomized controlled trials","author":"Asbaghi","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbadis.2025.167862_bb1340","first-page":"56","article-title":"Enzymatic and non-enzymatic Antioxidative effects of folic acid and its reduced Derivates","author":"Stanger","year":"2012","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbadis.2025.167862_bb1345","doi-asserted-by":"crossref","unstructured":"Murakami, K.; Miyake, Y.; Sasaki, S.; Tanaka, K.; Fukushima, W.; Kiyohara, C.; Tsuboi, Y.; Yamada, T.; Oeda, T.; Miki, T.; Kawamura, N.; Sakae, N.; Fukuyama, H.; Hirota, Y.; Nagai, M. Dietary intake of Folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan. Br. J. Nutr. 2010, 104 (5). doi:https:\/\/doi.org\/10.1017\/S0007114510001005.","DOI":"10.1017\/S0007114510001005"},{"key":"10.1016\/j.bbadis.2025.167862_bb1350","doi-asserted-by":"crossref","unstructured":"Van Der Zwaluw, N. L.; Dhonukshe-Rutten, R. A. M.; Van Wijngaarden, J. P. V.; Brouwer-Brolsma, E. M.; Van De Rest, O. V.D.; In't Veld, P. H.; Enneman, A. W.; Van Dijk, S. C.; Ham, A. C.; Swart, K. M. A.; Van Der Velde, N.; Van Schoor, N. M.; Van Der Cammen, T. J. M.; Uitterlinden, A. G.; Lips, P.; Kessels, R. P. C.; De Groot, L. C. P. G. M. Results of 2-year vitamin B treatment on cognitive performance; secondary data from an RCT. Neurology 2014, 83 (23). doi:https:\/\/doi.org\/10.1212\/WNL.0000000000001050.","DOI":"10.1212\/WNL.0000000000001050"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167862_bb1355","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/aje\/kwh213","article-title":"Folate intake and risk of Parkinson\u2019s disease","volume":"160","author":"Chen","year":"2004","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.bbadis.2025.167862_bb1360","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29383","article-title":"Long-term intake of Folate, vitamin B6, and vitamin B12 and the incidence of Parkinson\u2019s disease in a sample of U.S. women and men","volume":"38","author":"Flores-Torres","year":"2023","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167862_bb1365","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.7b00230","article-title":"Vitamin B12 inhibits tau fibrillization via binding to cysteine residues of tau","volume":"8","author":"Rafiee","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.bbadis.2025.167862_bb1370","doi-asserted-by":"crossref","DOI":"10.1039\/C8FO02471E","article-title":"Vitamin B12 inhibits \u03b1-Synuclein Fibrillogenesis and protects against amyloid-induced cytotoxicity","volume":"10","author":"Jia","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.bbadis.2025.167862_bb1375","doi-asserted-by":"crossref","unstructured":"McCarter, S. J.; Teigen, L. M.; McCarter, A. R.; Benarroch, E. E.; St. Louis, E. K.; Savica, R. Low vitamin B12 and Parkinson disease: potential link to reduced cholinergic transmission and severity of disease. Mayo Clin. Proc. 2019. doi:https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.039.","DOI":"10.1016\/j.mayocp.2019.01.039"},{"key":"10.1016\/j.bbadis.2025.167862_bb1380","doi-asserted-by":"crossref","DOI":"10.1017\/S1041610211002511","article-title":"Cognitive impairment and vitamin B12: a review","author":"Moore","year":"2012","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.bbadis.2025.167862_bb1385","doi-asserted-by":"crossref","unstructured":"Orozco-Barrios, C. E.; Battaglia-Hsu, S. F.; Arango-Rodriguez, M. L.; Ayala-Davila, J.; Chery, C.; Alberto, J. M.; Schroeder, H.; Daval, J. L.; Martinez-Fong, D.; Gueant, J. L. Vitamin B12-Impaired Metabolism Produces Apoptosis and Parkinson Phenotype in Rats Expressing the Transcobalamin-Oleosin Chimera in Substantia Nigra. PLoS One 2009, 4 (12). doi:https:\/\/doi.org\/10.1371\/journal.pone.0008268.","DOI":"10.1371\/journal.pone.0008268"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1390","doi-asserted-by":"crossref","DOI":"10.1186\/s40734-020-00085-8","article-title":"Vitamin B12 measurements across neurodegenerative disorders","volume":"7","author":"Luthra","year":"2020","journal-title":"J Clin Mov Disord"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167862_bb1395","article-title":"Characterization of vitamin B12 supplementation and correlation with clinical outcomes in a large longitudinal study of early Parkinson\u2019s disease","volume":"12","author":"Dietiker","year":"2019","journal-title":"J Mov Disord"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167862_bb1400","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27301","article-title":"Vitamin B12 and homocysteine levels predict different outcomes in early Parkinson\u2019s disease","volume":"33","author":"Christine","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1405","first-page":"73","article-title":"Higher vitamin B12 level at Parkinson\u2019s disease diagnosis is associated with lower risk of future dementia","author":"McCarter","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1410","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2014.10.010","article-title":"Peripheral nervous system involvement in Parkinson\u2019s disease: evidence and controversies","author":"Comi","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1415","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-020-04407-4","article-title":"Peripheral neuropathy in Parkinson\u2019s disease","author":"Paul","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbadis.2025.167862_bb1420","doi-asserted-by":"crossref","unstructured":"Corr\u00e0, M. F.; Vila-Ch\u00e3, N.; Sardoeira, A.; Hansen, C.; Sousa, A. P.; Reis, I.; Sambayeta, F.; Dam\u00e1sio, J.; Calejo, M.; Schicketmueller, A.; Laranjinha, I.; Salgado, P.; Taipa, R.; Magalh\u00e3es, R.; Correia, M.; Maetzler, W.; Maia, L. F. Peripheral neuropathy in Parkinson's disease: prevalence and functional impact on gait and balance. Brain 2023, 146 (1). doi:https:\/\/doi.org\/10.1093\/brain\/awac026.","DOI":"10.1093\/brain\/awac026"},{"key":"10.1016\/j.bbadis.2025.167862_bb1425","first-page":"11","article-title":"Changes of peripheral nerve function and vitamin B12 level in people with Parkinson\u2019s disease","author":"Qiu","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbadis.2025.167862_bb1430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2017.05.023","article-title":"Peripheral neuropathy in idiopathic Parkinson\u2019s disease: a systematic review","author":"Zis","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167862_bb1435","doi-asserted-by":"crossref","DOI":"10.1002\/mds.25585","article-title":"Neuropathy and levodopa in Parkinson\u2019s disease: evidence from a multicenter study","volume":"28","author":"Ceravolo","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2025.167862_bb1440","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awac225","article-title":"Vitamins B6and B12, levodopa, and their complex interactions in patients with Parkinson\u2019s disease","author":"Liz\u00e1rraga","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2025.167862_bb1445","doi-asserted-by":"crossref","unstructured":"Mancini, F.; Comi, C.; Oggioni, G. D.; Pacchetti, C.; Calandrella, D.; Coletti Moja, M.; Riboldazzi, G.; Tunesi, S.; Dal Fante, M.; Manfredi, L.; Lacerenza, M.; Cantello, R.; Antonini, A. Prevalence and Features of Peripheral Neuropathy in Parkinson's Disease Patients under Different Therapeutic Regimens. Parkinsonism Relat Disord 2014, 20 (1). doi:https:\/\/doi.org\/10.1016\/j.parkreldis.2013.09.007.","DOI":"10.1016\/j.parkreldis.2013.09.007"},{"key":"10.1016\/j.bbadis.2025.167862_bb1450","doi-asserted-by":"crossref","unstructured":"M\u00fcller, T.; Laar, T. van; Cornblath, D. R.; Odin, P.; Klostermann, F.; Grandas, F. J.; Ebersbach, G.; Urban, P. P.; Valldeoriola, F.; Antonini, A. Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery. Parkinsonism Relat. Disord. 2013. doi:https:\/\/doi.org\/10.1016\/j.parkreldis.2013.02.006.","DOI":"10.1016\/j.parkreldis.2013.02.006"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1455","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12010153","article-title":"Vitamin B12 ameliorates the pathological phenotypes of multiple Parkinson\u2019s disease models by alleviating oxidative stress","volume":"12","author":"Wu","year":"2023","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167862_bb1460","doi-asserted-by":"crossref","DOI":"10.1038\/s41422-019-0153-8","article-title":"Vitamin B 12 modulates Parkinson\u2019s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection","volume":"29","author":"Schaffner","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.bbadis.2025.167862_bb1465","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-021-01574-7","article-title":"New aspects of microbial vitamin K2 production by expanding the product Spectrum","author":"Zhang","year":"2021","journal-title":"Microb. Cell Factories"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1470","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-019-1179-9","article-title":"Long-chain vitamin K2 production in Lactococcus Lactis is influenced by temperature, carbon source, aeration and mode of energy metabolism","volume":"18","author":"Liu","year":"2019","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.bbadis.2025.167862_bb1475","doi-asserted-by":"crossref","unstructured":"Walther, B.; Chollet, M. Menaquinones, Bacteria, and foods: vitamin K2 in the diet. In vitamin K2 - Vital for Health and Wellbeing; 2017. doi:https:\/\/doi.org\/10.5772\/63712.","DOI":"10.5772\/63712"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1480","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1887721","article-title":"Dietary vitamin K is remodeled by gut microbiota and influences community composition","volume":"13","author":"Ellis","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbadis.2025.167862_bb1485","first-page":"3","article-title":"Newly identified vitamin K-producing Bacteria isolated from the neonatal Faecal Flora","volume":"18","author":"Cooke","year":"2006","journal-title":"Microb. Ecol. Health Dis."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167862_bb1490","doi-asserted-by":"crossref","DOI":"10.3390\/nu14102078","article-title":"Dietary vitamin B1 intake influences gut microbial community and the consequent production of short-chain fatty acids","volume":"14","author":"Park","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2025.167862_bb1495","first-page":"269","article-title":"Neuroprotective effect of vitamin K2 against gut Dysbiosis associated cognitive decline","author":"Chatterjee","year":"2023","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbadis.2025.167862_bb1500","article-title":"Vitamin K: a potential neuroprotective agent","author":"Chatterjee","year":"2023","journal-title":"Rev. Bras"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1505","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11033-022-07925-w","article-title":"The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence","volume":"50","author":"Emekli-Alturfan","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"16","key":"10.1016\/j.bbadis.2025.167862_bb1510","doi-asserted-by":"crossref","DOI":"10.18632\/aging.103691","article-title":"The Association of Serum Vitamin K2 levels with Parkinson\u2019s disease: from basic case-control study to big data mining analysis","volume":"12","author":"Yu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.bbadis.2025.167862_bb1515","doi-asserted-by":"crossref","DOI":"10.1134\/S0006297924140049","article-title":"The role of vitamin K in the development of neurodegenerative diseases","author":"Diachenko","year":"2024","journal-title":"Biochem. Mosc."},{"issue":"7","key":"10.1016\/j.bbadis.2025.167862_bb1520","doi-asserted-by":"crossref","DOI":"10.3390\/nu14071504","article-title":"Vitamin K2 modulates mitochondrial dysfunction induced by 6-Hydroxydopamine in SH-SY5Y cells via mitochondrial quality-control loop","volume":"14","author":"Tang","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2025.167862_bb1525","doi-asserted-by":"crossref","unstructured":"Vos, M.; Esposito, G.; Edirisinghe, J. N.; Vilain, S.; Haddad, D. M.; Slabbaert, J. R.; Van Meensel, S.; Schaap, O.; De Strooper, B.; Meganathan, R.; Morais, V. A.; Verstreken, P. Vitamin K2 is a mitochondrial Electron carrier that rescues Pink1 deficiency. Science (1979) 2012, 336 (6086). doi:https:\/\/doi.org\/10.1126\/science.1218632.","DOI":"10.1126\/science.1218632"},{"issue":"9","key":"10.1016\/j.bbadis.2025.167862_bb1530","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2016.68","article-title":"Vitamin K2 suppresses rotenone-induced microglial activation in vitro","volume":"37","author":"Yu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbadis.2025.167862_bb1535","first-page":"23 (5)","article-title":"Vitamin K2 protects PC12 cells against a\u03b2 (1-42) and H2O2-induced apoptosis via P38 MAP kinase pathway*","author":"Hadipour","year":"2020","journal-title":"Nutr. Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167862_bb1540","article-title":"Association of Vitamin K with cognitive decline and neuropathology in community-dwelling older persons","volume":"8","author":"Booth","year":"2022","journal-title":"Alzheimer\u2019s and Dementia: Translational Research and Clinical Interventions"},{"key":"10.1016\/j.bbadis.2025.167862_bb1545","doi-asserted-by":"crossref","unstructured":"Da Silva, F. L.; Coelho Cerqueira, E.; De Freitas, M. S.; Gon\u00e7alves, D. L.; Costa, L. T.; Follmer, C. Vitamins K Interact with N-Terminus \u03b1-Synuclein and Modulate the Protein Fibrillization in Vitro. Exploring the Interaction between Quinones and \u03b1-Synuclein. Neurochem Int 2013, 62 (1). doi:https:\/\/doi.org\/10.1016\/j.neuint.2012.10.001.","DOI":"10.1016\/j.neuint.2012.10.001"},{"key":"10.1016\/j.bbadis.2025.167862_bb1550","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-024-03109-4","article-title":"A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets","author":"Aziz","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbadis.2025.167862_bb1555","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3390\/biomedicines12081738","article-title":"The gut microbiome as a catalyst and emerging therapeutic target for Parkinson\u2019s disease: a comprehensive update","volume":"12","author":"Kerstens","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbadis.2025.167862_bb1560","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota\u2013gut\u2013brain Axis and its therapeutic applications in neurodegenerative diseases","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.167862_bb1565","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-024-00404-1","article-title":"Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside","author":"Ma","year":"2024","journal-title":"Translational Neurodegeneration."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:48:04Z","timestamp":1750268884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":313,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0925443925002108"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167862","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's disease and gut microbiota metabolites: The dual impact of vitamins and functional amyloids","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167862"}}